300119 logo

Tianjin Ringpu Bio-Technology Co.,Ltd. Stock Price

SZSE:300119 Community·CN¥8.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300119 Share Price Performance

CN¥0
-22.21 (-100.00%)
CN¥0
-22.21 (-100.00%)
Price CN¥0

300119 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with proven track record and pays a dividend.

1 Risk
4 Rewards

Tianjin Ringpu Bio-Technology Co.,Ltd. Key Details

CN¥3.4b

Revenue

CN¥2.0b

Cost of Revenue

CN¥1.4b

Gross Profit

CN¥991.9m

Other Expenses

CN¥392.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.86
40.68%
11.53%
28.9%
View Full Analysis

About 300119

Founded
1998
Employees
2803
CEO
Lei Xu
WebsiteView website
www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis and treatment services, such as epidemic diagnosis and testing, animal drug evaluation, and veterinary socialization. The company was founded in 1998 and is headquartered in Tianjin, China.

Recent 300119 News & Updates

Recent updates

No updates